as on December 9, 2025 at 2:29 am IST
Day's Low
Day's High
0.50%
Downside
4.03%
Upside
52 Week's Low
52 Week's High
56.40%
Downside
12.20%
Upside
Check Theravance Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$940.0M
EPS (TTM)
0.1167
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
32.54
Industry PE ratio
-0.4116938110749186
PEG Ratio
-0.05
EBITDA
-31.2M
Revenue (TTM)
80.3M
Profit Margin
36.53%
Return On Equity TTM
14.03%
Track how Theravance Biopharma Inc P/E has moved over time to understand its valuation trends.
Theravance Biopharma Inc in the last 5 years
Lowest (-41.07x)
September 30, 2025
Industry (-0.41x)
December 9, 2025
Today (32.54x)
December 9, 2025
Highest (-2.95x)
December 31, 2021
Today’s Price to Earnings Ratio: 32.54x
Compare market cap, revenue, PE, and other key metrics of Theravance Biopharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $940.0M | 0.44% | 32.54 | 36.53% | |
| BUY | $41.9B | 390.27% | -16.34 | -264.83% | |
| BUY | $60.5B | 246.68% | 1431.62 | 1.36% | |
| BUY | $116.8B | 97.01% | 32.05 | 31.35% | |
| BUY | $76.1B | 43.92% | 17.21 | 32.13% |
The Theravance Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Theravance Biopharma Inc investment value today
Current value as on today
₹1,87,521
Returns
₹87,521
(+87.52%)
Returns from Theravance Biopharma Inc Stock
₹81,381 (+81.38%)
Dollar Returns*
₹6,139 (+6.14%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Theravance Biopharma Inc. Average target price of $26.71
Get share price movements and forecasts by analysts on Theravance Biopharma Inc.
What analysts predicted
32.16%UPSIDE
Target Price
$26.71
Current Price
$18.12
Analyzed by
11 Analysts
Target
$26.71
Theravance Biopharma Inc target price $26.71, a slight upside of 32.16% compared to current price of $18.12. According to 11 analysts rating.
Search interest for Theravance Biopharma Inc Stock has increased by 200% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:200% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, TBPH stock has moved up by 22.8%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 964.7% return, outperforming this stock by 897.7%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.1% return, outperforming this stock by 88.7%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 54.83M → 3.61M (in $), with an average decrease of 93.4% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 26.19M → 19.99M (in $), with an average decrease of 23.7% per quarter
| Organisation | Theravance Biopharma Inc |
| Headquarters | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
| Industry | Health Technology |
| CEO | Mr. Rick E. Winningham M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Aine Miller Ph.D. | Senior VP of Development & Head of Ireland Office |
Mr. Rick E. Winningham M.B.A. | CEO & Director |
Mr. Aziz Sawaf C.F.A. | Senior VP & CFO |
Mr. Brett A. Grimaud Esq. | Senior VP, General Counsel & Secretary |
Mr. Stuart Knight | Senior VP of IT&I and Chief Information Officer |
Ms. Rhonda F. Farnum | Chief Business Officer and Senior VP of Commercial & Medical Affairs |
Ms. Stacy L. Pryce | Senior VP & Chief Strategy Officer |
Theravance Biopharma Inc share price today is $18.12 as on at the close of the market. Theravance Biopharma Inc share today touched a day high of $18.85 and a low of $18.03.
Theravance Biopharma Inc share touched a 52 week high of $20.33 on and a 52 week low of $7.9 on . Theravance Biopharma Inc stock price today i.e. is closed at $18.12,which is 10.87% down from its 52 week high and 129.37% up from its 52 week low.
Theravance Biopharma Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Theravance Biopharma Inc (TBPH) shares with as little as ₹90.066 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Theravance Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Theravance Biopharma Inc share’s latest price of $18.12 as on December 9, 2025 at 2:29 am IST, you will get 0.5519 shares of Theravance Biopharma Inc. Learn more about
fractional shares .
Theravance Biopharma Inc stock has given 0.44% share price returns and 22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?